W. Ian Lipkin, Director of the Center for Infection and Immunity and the Center for Solutions for ME/CFS at Columbia University, has written the following letter several days before the Fourth Annual Conference on Psychosomatics at Columbia University this weekend. The original letter can be found at this link.
18 October 2018
Dear Colleagues and Friends,
The Center for Infection and Immunity (CII) has been committed to ME/CFS research since 2010. We began this research with generous support from the Chronic Fatigue Initiative of the Hutchins Family Foundation, the National Institutes of Health, and the Microbe Discovery Project.
In 2017, the CII was selected to host one of three NIH centers funded for collaborative research into the biology of this disease. The Center for Solutions for ME/CFS (CfS for ME/CFS) includes representatives from #MEAction and Solve ME/CFS as well as clinical and basic scientists drawn from leading academic institutions and clinical sites across the United States.
Our studies of blood, cerebrospinal fluid, saliva and feces, using state-of-the-art methods that include microbial gene sequencing, metabolomics, proteomics, and immunological profiling, confirm that patients with ME/CFS have biological abnormalities that cannot be characterized as psychosomatic.
Committees convened by the National Academies of Sciences, the National Institutes of Health, and the Centers for Disease Control and Prevention have also concluded that ME/CFS is not a psychosomatic disorder.
We are committed to actively investigating the causes of immunological and metabolic abnormalities in ME/CFS. Our hope is that this work will enable insights that lead to treatments.
W. Ian Lipkin, MD
Director, Center for Infection & Immunity
Director, Center or Solutions for ME/CFS